Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis

Journal of Rheumatology

Volumn 30, Issue 2, 2003, Pages 401-403

  Ramanan, Athimalaipet V ^a   Schneider, Rayfel ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Etanercept; Hemophagocytic lymphohistiocytosis; Juvenile rheumatoid arthritis; Macrophage activation syndrome

Indexed keywords

ETANERCEPT; METHYLPREDNISOLONE; PREDNISONE;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MACROPHAGE ACTIVATION; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; TREATMENT OUTCOME; TREATMENT PLANNING; URTICARIA;

ANGIONEUROTIC EDEMA; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD, PRESCHOOL; FEMALE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; IMMUNOGLOBULIN G; MACROPHAGE ACTIVATION; MACROPHAGES; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0037311129     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Schneider R, Laxer RM. Systemic onset juvenile rheumatoid arthritis. Baillieres Clin Rheumatol 1998;12:245-71.
2. Heaton DC, Moller PW. Still's disease associated with Coxsackie infection and haemophagocytic syndrome. Ann Rheum Dis 1985;44:341-4.
3. Morris JA, Adamson AR, Holt PJ, Davson J. Still's disease and the virus associated haemophagocytic syndrome. Ann Rheum Dis 1984;44:349-53.
4. Ulsen MH, Grand RJ, Crain JD, Gelfand EW. Hepatotoxicity with encephalopathy associated with aspirin therapy in juvenile rheumatoid arthritis. J Pediatr 1978;93:1034-7.
5. Silverman ED, Miller JJ, Bernstein B, Shafai T. Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis. J Pediatr 1983;103:872-6.
6. Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drug or infection. J Pediatr 1985;106:561-6.
7. Ravelli A, Caria MC, Buratti S, Malattia C, Temporini F, Martini A. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 2001;28:865-7.
8. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection-and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12:435-44.
9. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticluar juvenile rheumatoid arthritis. N Engl J Med 2000;342:763-9.
10. Takei S, Groh D, Shaham B, et al. Safety and efficacy of high dose etarnacept in the treatment of juvenile rheumatoid arthritis [abstract]. Arthritis Rheum 2000;43 Suppl:S256.
11. Kimura Y, Li S, Ebner-Lyon L, Hackensack LI. Treatment of systemic JIA with etanercept: results of a survey [abstract]. Arthritis Rheum 2000;43 Suppl:S257.
12. Skytta E, Pohjankoski H, Savolainen A. Etanercept and urticaria in patients with juvenile idiopathic arthritis. Clin Exp Rheumatol 2000;18:533-4.
13. Stephan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM. Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 1993;11:451-6.
14. Imagawa T, Katakura S, Mori M, Aihara Y, Mitsuda T, Yokota S. A case of macrophage activation syndrome developed with systemic juvenile rheumatoid arthritis. Ryumachi 1997;37:487-92.
15. De Benedetti F, Pignatti P, Massa M, et al. Soluble tumour necrosis factor receptor levels reflect coagulation abnormalities in systemic juvenile rheumatoid arthritis. Br J Rheumatol 1997;36:581-8.
16. Prahalad S, Bove KE, Dickens D, Lovell DJ, Grom AA. Etanercept in treatment of macrophage activation syndrome. J Rheumatol 2001;28:2120-4.
17. Zeltser R, Valle L, Tonck C, Holyst MM, Ritchlin C, Gaspari AA. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor (alpha) receptor: Fc fusion protein. Arch Dermatol 2001;137:893-9.